Article
Improved HLA-based prediction of coeliac disease identifies two novel HLA risk modifiers, DQ6.2 and DQ7.3
2019-03-05
Abstract excerpt
<h4>Purpose</h4> Human Leukocyte Antigen (HLA) testing is useful in the clinical work-up of coeliac disease (CD), with high negative but low positive predictive value. We construct a genomic risk score (GRS) using HLA risk loci to improve CD prediction and guide exclusion criteria. <h4>Methods</h4> Imputed HLA genotypes for five European CD case-control GWAS (n>15,000) were used to construct and validate an HLA...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 49f6bb22-fc03-5456-8956-7571d8de089f
- DOI
- 10.1101/561308
